Sex, Antithrombotics, and Outcomes After TAVR: Is There More Difference Within Sexes or Between Them?

JACC Cardiovasc Interv. 2023 May 8;16(9):1103-1106. doi: 10.1016/j.jcin.2023.03.051.

Authors

Giulia Masiero¹, Giuseppe Tarantini²

Affiliations

¹ Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padua Medical School, Padua, Italy.
² Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padua Medical School, Padua, Italy. Electronic address: giuseppe.tarantini.1@gmail.com.

PMID: 37164610
DOI: 10.1016/j.jcin.2023.03.051

No abstract available

Keywords: antithrombotic therapy; aortic stenosis; bleeding; sex; transcatheter aortic valve replacement.

Publication types

Editorial
Comment

MeSH terms

Aortic Valve / diagnostic imaging
Aortic Valve / surgery
Aortic Valve Stenosis* / diagnostic imaging
Aortic Valve Stenosis* / surgery
Fibrinolytic Agents / adverse effects
Humans
Risk Factors
Transcatheter Aortic Valve Replacement* / adverse effects
Treatment Outcome

Substances

Fibrinolytic Agents